Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
1
x
$
0.00
VOL 2 No. 4 Full Issue - April 2000
1
x
$
20.00
Long-Term Outcomes of Post Dural Puncture Headache Treated With Epidural Blood Patch: A Pilot Study
1
x
$
30.00
The Role of Religiosity and Guilt in Symptomatology and Outcome of Obsessive Compulsive Disorder
1
x
$
30.00
The Sex Effects Scale: Pilot Validation in a Healthy Population
1
x
$
30.00
A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
1
x
$
30.00
David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
1
x
$
30.00
View Cart
Checkout
Home
tiagabine
“David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
